106312Brilliant Violet 421 trade antimouse CD152 and 3 more items
State & local contract award Virginia Awarded
- Contract number
- A236_P0358600
- Awardee
- BioLegend
- Contracting organization
- Virginia Commonwealth University
- Cumulative value
- $1,139
About this award
Virginia Commonwealth University (VCU) awarded a contract to BioLegend on October 5, 2026, for the procurement of research-grade flow cytometry reagents. The contract, identified as A236_P0358600, carries a cumulative value of $1,138.50 and is to be delivered to VCU Procurement in Virginia. The contract encompasses four distinct line items comprising monoclonal antibodies and viability assessment materials for laboratory use.
The deliverables include three Brilliant Violet-conjugated anti-mouse monoclonal antibodies targeting CD152, CD279, and CD69 markers, priced at $194.25, $120.00, and $321.75 respectively, with one unit of each ordered. Additionally, the contract specifies the procurement of two units of Zombie NIR Fixable Viability Kit at $251.25 per unit. These reagents are standard consumables utilized in flow cytometric analysis for immunological research applications. No annual value or specific contract performance period has been designated in the award documentation.
Line items
| Item | Total |
|---|---|
| 106312Brilliant Violet 421 trade antimouse CD152 | $194.25 |
| 135243Brilliant Violet 650 trade antimouse CD279 | $120.00 |
| 104532Brilliant Violet 510 trade antimouse CD69 | $321.75 |
| 423106Zombie NIR trade Fixable Viability Kit | $502.50 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A236_P0358600?
Contract A236_P0358600 was awarded to BioLegend by Virginia Commonwealth University on October 5, 2026.
How much is contract A236_P0358600 worth?
Its cumulative value is $1,139.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award